Everything we know today about gut health can be traced back to the scientific findings uncovered by the Human Microbiome Project (HMP). In fact, it was through this research that scientists discovered the microbiome within us has approximately 150 times more genes than the entire human body, providing evidence that the microbiome influences metabolism, physiology, and gene expression in ways that can impact mood, energy, and immune function.
Read more »
Fish oil has been studied for decades for its many health benefits including preventing and managing heart disease, lowering blood pressure, supporting eye health for the elderly, reducing triglycerides, and slowing the development of plaque in the arteries.*
At XYMOGEN we are committed to helping people achieve their best possible health. We believe that making our formulas available exclusively through healthcare practitioners, using quality ingredients, and educating our partners on breakthroughs in the industry are the ways we can deliver on that promise.
ORLANDO, Fla. –June 1, 2017 — XYMOGEN®, a leading health sciences company that manufactures exclusive functional medicine formulas, is excited to announce an increase in products, events, and staff in Canada.
ORLANDO, Fla. -- February 26, 2015 -- Orlando-based health sciences company XYMOGEN has announced it surpassed the Seven Million Dollar Month Revenue Milestone for January-2015. This represents the third consecutive January in which the company surpassed a Million-Dollar Milestone, reaching $5 million and $6 million in 2013 and 2014, respectively.
Dear Valued Customer,
I am writing you in response to the New York AG investigation of herbal supplements sold at retail outlets (GNC, Walgreens, Walmart, and Target).
Join us for the XYMOGEN® XPOSITION in Toronto, where we will explore diverse topics that will shift your views on health care. During this exclusive, one-day event, industry experts will present revolutionary tips to enhance both your practice and the health of your patients.
Orlando-based health sciences company XYMOGEN announced today that it has been recognized for the seventh time on Inc. Magazine’s Inc. 5000 list as one of the fastest growing and best run private companies in the nation.
Once again, the major media outlets are making a major splash with the negative news about niacin based on the HPS2-THRIVE study – first announced in March of 2013, and now again with the full publication of the study in the New England Journal of Medicine.
WE ARE VERY EXCITED TO SHARE OUR CULTURE AND PASSION FOR HEALTHCARE WITH YOU.